| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $85.5B | $82.7B | $78.6B | $89.9B | $67.4B | $10.0B | $13.7B | $54.1B |
| Cost of Revenue | $63.5B | $62.0B | $60.5B | $72.2B | $50.4B | $25.5B | $39.7B | $41.7B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.2B | $1.2B | $1.0B | $1.0B | $0.8B | $0.7B | $0.7B | $0.7B |
| Operating Income | $9.0B | $9.1B | $8.3B | $7.7B | $8.8B | $1.3B | $1.7B | $5.3B |
| Net Income | $4.4B | $4.8B | $3.9B | $4.8B | $5.5B | $-0.6B | $3.6B | $1.7B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $141.3B | $125.4B | $113.7B | $105.6B | $106.0B | $95.1B | $98.9B | $88.2B |
| Current Assets | $18.2B | $14.2B | $12.4B | $12.1B | $10.5B | $6.3B | $7.9B | $6.8B |
| Cash & Equivalents | $1.3B | $0.3B | $0.2B | $0.3B | $0.3B | $0.4B | $0.3B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $15.0B | $12.7B | $11.3B | $10.4B | $10.8B | $5.9B | $7.7B | $9.3B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.1B | $11.5B | $9.6B | $9.1B | $11.2B | — | — | $7.5B |
| Investing Cash Flow | $-8.4B | $-5.9B | $-4.3B | $-4.0B | $-2.8B | — | — | $-7.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-5.5B | $-5.3B | $-5.1B | $-8.4B | $-2.4B | $-1.2B | $-3.1B |